Literature DB >> 9155854

Nebulisers for patients with HIV infection and AIDS.

R F Miller1, M J O'Doherty.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9155854      PMCID: PMC1765873          DOI: 10.1136/thx.52.2008.s60

Source DB:  PubMed          Journal:  Thorax        ISSN: 0040-6376            Impact factor:   9.139


× No keyword cloud information.
  16 in total

1.  Dodging droplet nuclei. Reducing the probability of nosocomial tuberculosis transmission in the AIDS era.

Authors:  E A Nardell
Journal:  Am Rev Respir Dis       Date:  1990-09

2.  Differences in relative efficiency of nebulisers for pentamidine administration.

Authors:  M J O'Doherty; S Thomas; C Page; D Barlow; C Bradbeer; T O Nunan; N T Bateman
Journal:  Lancet       Date:  1988-12-03       Impact factor: 79.321

3.  Aerosolised pentamidine.

Authors: 
Journal:  Lancet       Date:  1989-11-25       Impact factor: 79.321

4.  Nebulised pentamidine as treatment for Pneumocystis carinii pneumonia in the acquired immunodeficiency syndrome.

Authors:  R F Miller; P Godfrey-Faussett; S J Semple
Journal:  Thorax       Date:  1989-07       Impact factor: 9.139

5.  Aerosol pentamidine for secondary prophylaxis of AIDS-related Pneumocystis carinii pneumonia. A randomized, placebo-controlled study.

Authors:  J S Montaner; L M Lawson; A Gervais; R H Hyland; C K Chan; J M Falutz; P M Renzi; D MacFadden; A R Rachlis; I W Fong
Journal:  Ann Intern Med       Date:  1991-06-01       Impact factor: 25.391

6.  CD4 counts as predictors of opportunistic pneumonias in human immunodeficiency virus (HIV) infection.

Authors:  H Masur; F P Ognibene; R Yarchoan; J H Shelhamer; B F Baird; W Travis; A F Suffredini; L Deyton; J A Kovacs; J Falloon
Journal:  Ann Intern Med       Date:  1989-08-01       Impact factor: 25.391

7.  Pentamidine aerosol versus trimethoprim-sulfamethoxazole for Pneumocystis carinii in acquired immune deficiency syndrome.

Authors:  A B Montgomery; D W Feigal; F Sattler; G R Mason; A Catanzaro; R Edison; N Markowitz; E Johnson; S Ogawa; M Rovzar
Journal:  Am J Respir Crit Care Med       Date:  1995-04       Impact factor: 21.405

8.  Aerosolised pentamidine as sole therapy for Pneumocystis carinii pneumonia in patients with acquired immunodeficiency syndrome.

Authors:  A B Montgomery; R J Debs; J M Luce; K J Corkery; J Turner; E N Brunette; E T Lin; P C Hopewell
Journal:  Lancet       Date:  1987-08-29       Impact factor: 79.321

9.  The risk of Pneumocystis carinii pneumonia among men infected with human immunodeficiency virus type 1. Multicenter AIDS Cohort Study Group.

Authors:  J Phair; A Muñoz; R Detels; R Kaslow; C Rinaldo; A Saah
Journal:  N Engl J Med       Date:  1990-01-18       Impact factor: 91.245

10.  Pulmonary tolerance of prophylactic aerosolized pentamidine in human immunodeficiency virus-infected patients.

Authors:  F Camus; C de Picciotto; A Leprêtre; R Landman; P M Girard
Journal:  Chest       Date:  1991-03       Impact factor: 9.410

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.